AAPS Announces 2002 Leadership
President-Elect, Two Members-At-Large Elected to Lead Scientific Association

ARLINGTON, Va. - Vinod P. Shah, Ph.D., Senior Research Scientist, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), has been voted President-Elect for the 11,000-member American Association of Pharmaceutical Scientists (AAPS). He joins 2002 AAPS President Diane J. Burgess, Ph.D., Immediate Past President Ronald T. Borchardt, Ph.D., and Treasurer Marjorie A. Mohler, Ph.D., as officers on the 2002 AAPS Executive Council.

“I am excited about advancing the cause of AAPS and making a difference in the pharmaceutical sciences,” said Shah. “AAPS is now one of the most prestigious associations of its kind in the world. AAPS must be responsive to the diversified needs and wishes of all of its members. During my tenure, I will strive to develop strategies to increase the influence and enhance the prestige of pharmaceutical sciences worldwide, expand the cutting-edge meetings and workshops in partnership with other national and international professional associations, and develop means to effectively distribute its knowledge internationally.”

Dr. Shah is author/co-author of more than 175 scientific publications. Shah has been the recipient of several awards during his career in pharmaceutical science including: CDER/FDA awards for leadership excellence, team excellence and excellence in communication, FDA Awards of Merit (1981,1988) and Scientific Achievement (2000), AAPS Presidential Citation (1989) and AAPS Distinguished Service Award (2000).

The two new AAPS Members-at-Large, elected to a three-year term, are Steven J. Shire, Ph.D., Senior Research Scientist, Genentech, Inc. and Kevin R. Sweeney, Ph.D., Associate Professor of Pharmaceutics, University of Connecticut.

Newly elected AAPS Section leaders include:

• Analysis and Pharmaceutical Quality (APQ) Secretary/Treasurer William E. Weiser, Ph.D., Magellan Laboratories, Inc.
• Biotechnology (BIOTEC) Vice Chair Wayne R. Gombotz, Ph.D., Immunex Corporation
• Clinical Sciences (CS) Vice Chair Natalie D. Eddington, Ph.D., University of Maryland
• Medicinal and Natural Products Chemistry (MNPC) Vice Chair Ian S. Haworth, Ph.D., University of Southern California and Secretary Robert L. Chapman, Ph.D., Midwestern University
• Economic, Marketing and Management Sciences (EMMS) Vice Chair Thani Jambulingam, Ph.D., St. Joseph’s University and Secretary William Doucette, Ph.D., University of Iowa
• Pharmaceutics and Drug Delivery (PDD) Vice Chair Philip L. Smith, Ph.D., GlaxoSmithKline and Secretary/Treasurer Mansoor A. Kahn. Ph.D., Texas Tech University Health Sciences Center 
• Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM) Vice Chair David Mitchell, Ph.D., Pfizer, Inc. and Secretary/Treasurer Gary A. Thompson, Ph.D., Procter and Gamble Pharmaceuticals 
• Pharmaceutical Technologies (PT) Vice Chair Anil Salpekar, Ph.D., DSM Catalytica Pharmaceuticals 
• Regulatory Sciences (RS) Vice Chair Uday B. Kompella, Ph.D., University of Nebraska Medical Center and Secretary/Treasurer Srikumaran Melethil, Ph.D., University of Missouri at Kansas City

These leaders assume their new roles on January 1, 2002.

About AAPS
AAPS is a professional, scientific society of more than 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Pharmaceutica at www.aapspharmaceutica.com .

*     *     *